Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
Clinical trial NCT02122822 · COMPLETED
Trial details
- NCT number
- NCT02122822
- Sponsor
- Cure&Sure Biotech Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.